［1］ Parkin D M，Bray F，Ferlay J.Estimating the world cancer burden:GLOBOCAN 2000［J］．Int Cancer，2001，94:153-156.

［2］ Ng S H, Ko S F, Toh C H,et al. Imaging of neck metastases ［J］ .Chang Gung Med J, 2006, 29(2):119-129.

［3］ 郑 航,陈锦章,罗荣城,等.18FFDG PET/CT显像对宫颈癌诊断及治疗的影响［J］.实用癌症杂志, 2009, 24(5):494-497.

［4］ Bjurberg M, Kjellén E, Ohlsson T,et al. FDG-PET in cervical cancer: Staging, restaging and follow-up［J］. Acta Obstet Gynecol Scand, 2007, 86:1384-1391.

［5］ Sironi S, Buda A, Picchio M,et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: Detection with inte-grated FDG PET/CT［J］. Radiology, 2006, 238(1):272-279.

［6］ Yen T C, See L C, Lai C H,et al.18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression［J］. J Nucl Med, 2004, 45 (10): 22-29.

［7］ Ong L C,Jin Y, Song I C,et al. 2-［18F］-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II［J］. Acta Radiol, 2008, 49(10):1145-1153.

［8］ Ronco G, Cuzick J, Pierotti P,et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening randomised controlled trial［J］.BMJ,2007,335(7609):28-34.

［9］ Arbyn M, Anttila A, Jordan J,et al. European Guidelines for Quality Assurance in Cervical Cancer Screening（ Second edition-summary document）［J］. Anna Oncol,2010,21(3):448-458.

［10］ Celik C, Gezginc K, Toy H,et al. A comparison of liquid based cytology with conventional cytology［J］. Int J Gynaecol Obstet, 2008,100(2):163-166.

［11］ Arbyn M, Sasieni P, Meijer C J, et al. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses［J］.Vaccine,2006,24（Suppl 3）:78-89.

［12］ Naucler P,Ryd W,T?rnberg S,et al.Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening［J］.J Natl Cancer Inst,2009,101（2）:88-99.

［13］ Kitchener H C,Almonte M,Thomson C,et al.HPV testing in combination with liquid-based cytology in primary cervical screening（ARTISTIC）:a randomised controlled trial［J］.Lancet Oncol,2009,10（7）:672-682.

［14］ 杨柳光，蒋利君，李卓园．基因芯片技术在HPV分型检测中的运用［J］.广西医学，2005，27(8):1163-1165．

［15］ Heselmeyer-Haddad K，Janz V，Castle P E，et al．Detection of genomic amplification of the human telomerase gene(TERC)in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia［J］．Am J Pathol，2003，163(4):1406-1416．

［16］ Heselmeyer-Haddad K，Sommerfeld K，White N M，et al．Genomic amplification of the human telomerase gene(TERC)in pap smears predicts the development of cervical cancer［J］．Am J Pathol，2005，166(4):1229-1238．

［17］ 高 莉,朱 炎,刘素萍,等.人端粒酶RNA基因荧光原位杂交检测在宫颈细胞学 检查中的应用［J］.中华病理学杂志，2011,40(2):104-107.

［18］ 江 静,魏丽惠,吴瑞芳,等.应用TERC基因检测子宫颈病变的临床研究［J］．中华妇产科杂志，2009，44(12):883-886．

［19］ Looi M L，Karsani S A，Rahman M A，et al．Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma［J］．Biosci，2009，34:917－925．

［20］ Zhu X，Lv J，Yu L，et al．Proteomic identification of differentially-expressed proteins in squamous cervical cancer［J］．Gynecol Oncol，2009，112:248-256．

［21］ Wong Y F，Cheung T H，Lo KWK，et al．Protein profiling ofcervical cancer by protein-biochips proteomic scoring to discriminate cervical cancer from normal cervix［J］．Cancer Letters，2004，21l:227-234．